Your Health, We Care
Exkivity is an oral tyrosine kinase inhibitor (TKI). The Exkivity version produced by Lucius has a specification of 40mg * 120 pills and is currently priced at $621.
The price of Exkivity may be influenced by various factors, including production costs and market demand.
The current price of Mobocertinib after medical insurance reimbursement in China···【more】
Release date：2026-02-26Recommended：68
The current price of Mobocertinib is influenced by purchasing channels, regional···【more】
Release date：2026-02-26Recommended：88
What is Exkivity?Molablotinib is a novel EGFR-TKI (epidermal growth factor recep···【more】
Release date：2024-11-29Recommended：228
The price of Exkivity varies depending on a number of factors, including the ver···【more】
Release date：2024-08-06Recommended：256
Exkivity is an orally targeted drug targeting EGFR gene mutations for the treatm···【more】
Release date：2024-08-06Recommended：283
Exkivity is a targeted therapy for specific types of non-small cell lung cancer ···【more】
Release date：2024-08-06Recommended：272
